NEFL and polyneuropathy: Levels of serum NfL were also studied longitudinally in a group of seven TTRv carriers who progressed during a median follow-up of ten years from asymptomatic TTRv carriers to symptomatic ATTRv amyloidosis patients with NCS-confirmed polyneuropathy.